Bristol Myers Squibb Co.

66
Hold
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US1101221083
USD
51.95
0.99 (1.94%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Bristol Myers Squibb Co. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-8,379.00
8,440.00
7,713.00
8,098.00
-6,871.00
4,975.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
810.00
-1,914.00
-2,229.00
-1,253.00
983.00
3,065.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
15,190.00
13,860.00
13,066.00
16,207.00
14,052.00
8,067.00
Cash Flow from Investing Activities
-21,352.00
-2,295.00
-1,062.00
-538.00
-10,859.00
-9,770.00
Cash Flow from Financing Activities
5,127.00
-9,416.00
-16,962.00
-16,224.00
-1,151.00
7,621.00
Net Cash Inflow / Outflow
-1,172.00
2,194.00
-4,991.00
-657.00
2,153.00
5,909.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-137.00
45.00
-33.00
-102.00
111.00
-9.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Bristol Myers Squibb Co.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-8379
8023
-16,402.00
-204.44%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
810
-3066
3,876.00
126.42%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
15190
12744
2,446.00
19.19%
Cash Flow from Investing Activities
-21352
2652
-24,004.00
-905.13%
Cash Flow from Financing Activities
5127
-17140
22,267.00
129.91%
Net Cash Inflow / Outflow
-1172
-1810
638.00
35.25%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-137
-66
-71.00
-107.58%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 9.60% vs 6.08% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
15,190.00
13,860.00
9.60%